Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 18/20 | 0.56 |
| ▸ | TPSB2 | P20231 | 8/20 | 0.39 |
| ▸ | F11 | P03951 | 7/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30010033 | 1.00 | CFD (0.56) | CFDTPSB2F11MAOBPDCD1 | |
| SCHEMBL21437760 | 0.93 | CFD (0.64) | CFDTPSB2F11 | |
| SCHEMBL29633958 | 0.93 | CFD (0.64) | CFDTPSB2F11 | |
| SCHEMBL21437872 | 0.92 | CFD (0.53) | CFDTPSB2F11PDCD1CD274 | |
| SCHEMBL21438538 | 0.91 | CFD (0.55) | CFDTPSB2F11PDCD1CD274 | |
| SCHEMBL23241665 | 0.91 | CFD (0.52) | CFDTPSB2F11PDCD1CD274 | |
| SCHEMBL23217653 | 0.91 | CFD (0.52) | CFDTPSB2F11PDCD1CD274 | |
| SCHEMBL30009776 | 0.91 | CFD (0.52) | CFDTPSB2F11PDCD1CD274 | |
| SCHEMBL23240918 | 0.90 | CFD (0.68) | CFDTPSB2F11 | |
| SCHEMBL23217818 | 0.90 | CFD (0.68) | CFDTPSB2F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114555570-A | Oral complement factor D inhibitors | 拜奥克里斯特制药公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2021072156-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |
| WO-2021072156-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |